Target Name: DCST1
NCBI ID: G149095
Review Report on DCST1 Target / Biomarker Content of Review Report on DCST1 Target / Biomarker
DCST1
Other Name(s): SNKY | DCST1 variant 2 | DC-STAMP domain-containing protein 1 | DC-STAMP domain containing 1, transcript variant 2 | DC-STAMP domain containing 1 | DC-STAMP domain containing 1, transcript variant 1 | E3 ubiquitin-protein ligase DCST1 (isoform 2) | E3 ubiquitin-protein ligase DCST1 | DCST1_HUMAN | E3 ubiquitin-protein ligase DCST1 (isoform 1) | SPE49 | RING-type E3 ubiquitin transferase | DCST1 variant 1

Exploring The Potential of DCST1 as A Drug Target for Male Infertility

DCST1 (Deleted in azoospermia-1), also known as SNKY, is a gene that has been identified as a potential drug target for the treatment of male infertility. DCST1 is a non-coding RNA molecule that has been shown to play a role in the development and maintenance of male infertility. In this article, we will explore the biology of DCST1 and its potential as a drug target.

Basic Biology

DCST1 is a gene that encodes a non-coding RNA molecule that is located on the X chromosome. DCST1 is one of several genes that have been identified as potential drug targets for the treatment of male infertility. In male infertility, the ability of sperm to fertilize eggs is often impaired, leading to the development of infertility. DCST1 has been shown to play a role in the development and maintenance of male infertility by regulating the development of testes and sperm.

DCST1 is expressed in a variety of tissues and cells, including testes, epididymis, and seminal vesicles. It has been shown to be involved in the development and maintenance of male fertility by regulating the development of testes and sperm. DCST1 has also been shown to play a role in the regulation of sexual behavior and desire.

DCST1 has been shown to be involved in the development and maintenance of male fertility by regulating the development of testes and sperm. In male infertility, the ability of sperm to fertilize eggs is often impaired, leading to the development of infertility. DCST1 has been shown to play a role in the development and maintenance of male fertility by regulating the development of testes and sperm.

Potential Drug Target

DCST1 has been identified as a potential drug target for the treatment of male infertility. The development and maintenance of male fertility are often impaired in male infertility, and DCST1 has been shown to play a role in the regulation of male fertility.

One potential way to target DCST1 is through the use of drugs that can inhibit the activity of DCST1. These drugs could be used to treat male infertility by restoring the ability of sperm to fertilize eggs.

Another potential way to target DCST1 is through the use of drugs that can increase the expression of DCST1. These drugs could be used to treat male infertility by increasing the number of testes and sperm in the body.

Conclusion

In conclusion, DCST1 is a gene that has been identified as a potential drug target for the treatment of male infertility. The development and maintenance of male fertility are often impaired in male infertility, and DCST1 has been shown to play a role in the regulation of male fertility. DCST1 is a promising target for the development of new treatments for male infertility. Further research is needed to fully understand the role of DCST1 in male infertility and to develop effective treatments.

Protein Name: DC-STAMP Domain Containing 1

Functions: E3 ubiquitin-protein ligase which mediates 'Lys-48'-linked ubiquitination of STAT2 and induces its proteosomal degradation thereby negatively regulating type-I-interferon signaling. Essential sperm cell-surface protein required for sperm-egg fusion and fertilization (By similarity)

The "DCST1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DCST1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DCST1-AS1 | DCST2 | DCSTAMP | DCT | DCTD | DCTN1 | DCTN1-AS1 | DCTN2 | DCTN3 | DCTN4 | DCTN5 | DCTN6 | DCTPP1 | DCUN1D1 | DCUN1D2 | DCUN1D3 | DCUN1D4 | DCUN1D5 | DCX | DCX (DDB1-CUL4-X-box) E3 protein ligase complex | DCX DET1-COP1 ubiquitin ligase complex | DCX(DCAF15) E3 protein ligase complex | DCXR | DDA1 | DDAH1 | DDAH2 | DDB1 | DDB2 | DDC | DDC-AS1 | DDD core complex | DDHD1 | DDHD2 | DDI1 | DDI2 | DDIAS | DDIT3 | DDIT4 | DDIT4L | DDN | DDO | DDOST | DDR1 | DDR2 | DDRGK1 | DDT | DDTL | DDX1 | DDX10 | DDX11 | DDX11-AS1 | DDX11L1 | DDX11L10 | DDX11L2 | DDX11L8 | DDX11L9 | DDX12P | DDX17 | DDX18 | DDX18P1 | DDX19A | DDX19A-DT | DDX19B | DDX20 | DDX21 | DDX23 | DDX24 | DDX25 | DDX27 | DDX28 | DDX31 | DDX39A | DDX39B | DDX39B-AS1 | DDX3P1 | DDX3X | DDX3Y | DDX4 | DDX41 | DDX42 | DDX43 | DDX46 | DDX47 | DDX49 | DDX5 | DDX50 | DDX50P1 | DDX51 | DDX52 | DDX53 | DDX54 | DDX55 | DDX56 | DDX59 | DDX59-AS1 | DDX6 | DDX60 | DDX60L | DDX6P1 | DEAF1